Investigational Drugs List
Groups Distribution
Phase Distribution
Filter Conditions
Investigational Drugs List
| Drugs ID | CID | Drugs | Identifier | Molecular Formula | Molecular Weight | Groups | US Approved | Details |
|---|---|---|---|---|---|---|---|---|
| Drug11 | 2353 | Berberine | NCT02962245 | C20H18NO4+ | 336.40 | experimental | NO | Details |
| Drug12 | 2519 | Caffeine | NCT03358706, NCT02760615 | C8H10N4O2 | 194.19 | approved | YES | Details |
| Drug13 | 2662 | Celecoxib | NCT00640809, NCT05960864 | C17H14F3N3O2S | 381.40 | approved|investigational | YES | Details |
| Drug14 | 2764 | Ciprofloxacin | NCT01772615, NCT00355602, NCT02765256???CT00257699 | C17H18FN3O3 | 331.34 | approved|investigational | YES | Details |
| Drug15 | 2812 | Clotrimazole | NCT00061282 | C22H17ClN2 | 344.80 | approved | YES | Details |
| Drug16 | 2907 | Cyclophosphamide | NCT03219359 | C7H15Cl2N2O2P | 261.08 | approved|investigational | YES | Details |
| Drug17 | 3339 | Fenofibrate | NCT05781698, NCT05753267 | C20H21ClO4 | 360.80 | approved | YES | Details |
| Drug18 | 3365 | Fluconazole | NCT02765256 | C13H12F2N6O | 306.27 | approved | YES | Details |
| Drug19 | 3446 | Gralise | NCT01678911 | C9H17NO2 | 171.24 | approved|investigational | YES | Details |
| Drug20 | 3652 | Hydroxychloroquine | NCT05119140 | C18H26ClN3O | 335.90 | approved | YES | Details |